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Abstract 
Review on t(10;14)(q24;q11) and t(7;10)(q34;q24) 
translocations, with data on clinics, and the genes 
involved. 
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Identity 
t(10;14)(q24;q11) or t(7;10) TLX1/TRD or TRB  
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Left: Partial karyograms showing t(10;14)(q24;q11), GTG-banding - Courtesy Tatiana Gindina. Right: top: 
t(10;14)(q24;q11) R-banding - Courtesy Pascale Cornillet-Lefebvre and Stéphanie Struski; middle and bottom: 
t(10;14)(q24;q11) R-banding - Courtesy Karolien Beel, Peter Meeus and Lucienne Michaux 
Clinics and pathology 
Disease 
T-cell acute lymphoblastic leukemia (ALL) and non-
Hodgkin lymphoma (NHL) with medullary 
involvement.  
 
A t(10;14)(q24;q11)TLX1/TRD was found in 69 
cases of T-ALL (Dube et al., 1986; Raimondi et al., 
1988; Kagan et al., 1989; Uckun et al., 1989; Parket 
al, 1992; Secker-Walker et al., 1992; Martin et al, 
1996; Rack et al., 1997; Forestier et al., 1998; 
Heerema et al., 1998; Lai et al., 2000; Schneider et 
al., 2000; Kahl et al., 2001; Pedersen et al., 2001; 
Thomas et al., 2001; Mancini et al., 2002; Nordgren 
et al., 2002; Kristensen et al., 2003; Barber et al., 
2004; Speleman et al., 2005; Stergianou et al., 2005; 
Cauwelier et al., 2006; Reichard et al., 2006; van 
Grotel et al., 2006; Strefford et al., 2007; Kwon et 
al., 2009; Le Noir et al., 2012; Setoodeh & Zhang, 
2012; Grossmann et al., 2013; Park et al., 2014; 
Safavi et al., 2015; Gindina T.  three personal 
unpublished cases).  
 
A t(7;14)(q34;q24) TLX1/TRB was found in 21 
cases of T-ALL (Kahl et al., 2001; Cauwelier et al., 
2006; Le Noir et al., 2012; Raimondi et al., 1988).  
 
In exceptional cases, a t(10;14) or a t(7;10) was 
found in T-prolymphocytic leukemia and ataxia 
telangiectasia (Rack et al., 1997), and, more 
surprisingly, in chronic lymphocytic leukemia, a B-
cell disease (Delhomme-Bachy et al., 1992; Lu et al., 
2006). 
Phenotype/cell stem origin 
T lineage. The gene expression pattern of TLX1-
expressing lymphoblasts is similar to that of early 
cortical thymocytes, compatible with a leukemic 
arrest at the stage of the early cortical thymocyte 
(virtually all arrested at the early cortical (CD1+) 
CD4+ CD8+ "double-positive" stage of thymocyte 
development). 
Epidemiology 
Found in 5% of pediatric T-ALL (0.3% of all 
pediatric ALL) and 30% of adult T-ALL cases. 
Median age was 24 years (range 4-58). Sex ratio was 
3 male : 1 female patients. 
Clinics 
Organomegaly with marked hepatosplenomegaly, 
lymphadenopathy, mediastinal mass, high WBC 
count (100 to 200 X 109/l) sometimes with anemia. 
Cytology 
High leukocyte count, very high circulating and 
central blast cell count. 
Prognosis 
TLX1 expression has been linked with a favorable 
prognosis and low risk of relapse in children and 
adults (van Vlierberghe et al., 2012). TLX1+ patients 
have a 92% probability of survival at 5 years. The 
lack of expression of anti-apoptotic genes in this 
stage of thymocyte development (and in TLX1-
expressing lymphoblasts) leads to a high 
responsiveness to drug-induced apoptosis. 
Genetics 
Note 
t(10;14)(q24;q11) or t(7;10) TLX1/TRD or TRB  
 
Atlas Genet Cytogenet Oncol Haematol. 2018; 22(9) 390 
 
Both translocations t(10;14)(q24;q11.2) and 
t(7;10)(q34;q24) are insufficient to initiate 
malignancy in mice: activation of other mutant 
genes, including NOTCH1, is found in most TLX1+ 
T-ALL. This finding suggests that multiple 
cooperating changes, leading to impaired DNA 




Top: Translocation t(10;14)(q24;q11) in a 32-year-old male with T-ALL and OS 33 months+ - Courtesy Tatiana 
Gindina. Bottom: Complex karyotype with two translocations t(10;14)(q24;q11) and t(11;14)(p13;q11), 
deletions of 3q, 9p, trisomy 20 in a 31-year-old female with T-ALL and OS 37 months - Courtesy Tatiana 
Gindina. 
Additional anomalies 
Additional chromosome anomalies were observed in 
about half of the cases (Dube et al., 1986; Raimondi 
et al., 1988; Kagan et al., 1989; Rack et al., 1997; 
Forestier et al., 1998; Lai et al., 2000; Schneider et 
al., 2000; Kahl et al., 2001; Pedersen et al., 2001; 
Mancini et al., 2002; Nordgren et al., 2002; 
Kristensen et al., 2003; Barber et al., 2004; Speleman 
et al., 2005; Stergianou et al., 2005; Cauwelier et al., 
2006; Reichard et al., 2006; Strefford et al., 2007; Le 
Noir et al., 2012; Setoodeh & Zhang, 2012; 
Grossmann et al., 2013; Safavi et al., 2015; Gindina 
T., three personal cases). The most common of them 
t(10;14)(q24;q11) or t(7;10) TLX1/TRD or TRB  
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are deletions of 9p (17%), 6q (13%), and 12p (9%). 
Deletions of 11p, 6p, 3q, 7q, 13q were less common. 
Trisomy 8 was present in 6 (7%) patients, and 
trisomy 20 was in 4 (4,5%) patients. Trisomies of 
other chromosomes were detected very seldom. In 
34 (38%) cases the translocations t(10;14) and 
t(7;10) were a part of a complex karyotype. 
Genes involved and 
proteins 




Alias HOX11 (homeobox 11) alias TCL3 (T-cell 
leukemia 3). 
DNA/RNA 
spans over 7 kb, 3 exons, mRNA 7 kb 
Protein 
The homeobox gene TLX1 (HOX11) encodes for 
TLX1, a homedomain-containing transcription 
factor, nuclear transcription factor that belongs to the 
NK-linked or NK-like subfamily of homeobox 
genes. TLX1 is the founding member of a family of 
HOX genes, homeoprotein, 61 amino acids, nuclear 
localization. It binds to the DNA sequence 5'-
GGCGGTAAGTGG-3'. The encoded protein is 
required and critical for normal development of the 
spleen during embryogenesis and is also involved in 
specification of neuronal cell fate. TLX1 is not 
normally expressed in adult tissues at levels 
detectable by routine Northern analysis.  
 
TLX-1 leukemias show specific cooperating 
mutations rarely present in non-TLX-induced 
leukemias, including the NUP214 / ABL1 fusion  
oncogene and mutations in the PTPN2, Wilms tumor 
1 (WT1), and PHF6 tumor supressors (van 
Vlierberghe et al., 2012). 




or TRB in the case of a 7q34-36 involvement 
Protein 
T-cell receptor 




Both translocations place TLX1 under the control of 
strong enhancers in the T-cell receptor loci. The 
t(10;14) translocation places the TLX1 coding 
region under the transcriptional control of the TCR 
delta receptor (TRD)( 14q11.2) promoter, the t(7;10) 
translocation places the TLX1 coding region under 
the transcriptional control of the TCR beta locus 
(TRB)(7q34-36), both leading to increased 
expression of TLX1 in T-cells. The t(10;14) can be 
detected by PCR, and a dual-color FISH probe is 
often used to detect HOX11 translocations on 10q24. 
However, TLX1 overexpression in leukemic blasts 
has been observed in the absence of 10q24 
rearrangement in as many as 50% of T-ALL cases. 
Oncogenesis 
These genetic aberrations induce aberrant and 
abundant TLX1 expression in T- lineage cells 
bearing the translocation. In addition, it was recently 
proposed that the unique cortical thymic maturation 
arrest in TLX-induced leukemias may be related to 
the binding of TLX1- ETS1 complexes to TCRA 
enhancer sequences, with the consequent down 
regulation of TCRA gene rearrangement and 
expression (van Vlierberghe et al., 2012).  
 
TLX1 overexpressing lymphoblasts are arrested at 
the stage of beta-selection in the thymocyte 
development. Leukemogenesis results from 
decreased cell death and increased proliferation of 
immature TLX1 expressing thymocytes, in the 
absence of normal DNA repair systems. The lack of 
anti-apoptotic actors in this stage explains the high 
responsiveness to chemotherapy, and the associated 
excellent outcome. 
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